Official Release of Achievements

In 2025, Manners Technology, a precision medical device manufacturer, officially announced the full‑scale mass production of its new‑generation AVF (Arteriovenous Fistula) access needles built on the technological platform of ultra‑pure medical‑grade stainless steel and nanoscale ultra‑precision finishing. Manufactured from ultra‑low‑interstitial 316L‑VAR (Vacuum‑Arc‑Remelted) stainless steel, the product features mirror‑level smoothness with an inner cannula surface roughness (Ra) ≤ 0.1 μm achieved via 5‑axis ultra‑precision laser cutting and molecular‑level electropolishing. Clinical data shows that dialysis puncture using this needle yields a first‑attempt success rate of 99.2 %, a 40 % reduction in puncture‑related intimal vascular injury, and an ultra‑high biosafety standard with endotoxin levels < 0.01 EU/mL, delivering extremely reliable physical protection for dialysis patients' "lifelines".

R&D Background and Clinical Pain Points

Arteriovenous fistulae serve as lifelines for haemodialysis patients, and AVF needles are devices used to access them several times weekly. Conventional AVF needles face severe challenges under long‑term repeated puncture:

Risks of material corrosion and ion leaching: Subjected to prolonged blood contact and repeated disinfection, ordinary stainless steel may suffer pitting corrosion, leading to potential leaching of chromium and nickel ions that trigger allergic or inflammatory reactions and accelerate fistula stenosis.

Trade‑off between tip sharpness and durability: Extreme sharpness is required to minimise puncture pain, yet tips easily roll or dull when puncturing hardened fistulae at high frequencies, causing difficult subsequent punctures and aggravated tissue damage.

Blood trauma caused by rough inner surfaces: Micro‑scratches from conventional drawing processes on inner cannula walls activate platelets and damage blood cells under blood flow impacts of 200–400 mL/min, raising risks of coagulation and micro‑inflammatory states.

Cleaning dead zones and pyrogen contamination: Complex junctions between hubs and cannula lumens are difficult to thoroughly clean, and residual processing grease or particles may induce pyrogenic reactions.

Core Technological Innovations

Starting from fundamental material properties and manufacturing limits, the manufacturer has established three core technological pillars:

Material upgrading and full‑chain traceability: Replacing conventional 316L stainless steel with medical‑grade 316L‑VAR stainless steel. The VAR process drastically reduces non‑metallic inclusions and bubbles within the material, boosting its Pitting Resistance Equivalent Number (PREN) by 25 % and enhancing fatigue resistance. Each batch of raw material is accompanied by material certificates traceable to individual melting heats, ensuring compositional purity and consistency.

5‑axis femtosecond laser precision cutting and slotting: A 5‑axis ultrafast femtosecond laser system adopted for cardiovascular stent manufacturing is utilised. With ultra‑high tolerances of ± 0.01 mm, the technology cuts hydrodynamically optimised side holes and drainage slots into cannula sidewalls. The cold‑processing property of femtosecond lasers eliminates heat‑affected zones, producing burr‑free and bead‑free cuts for inherently smooth orifices.

Multi‑step composite ultra‑finishing and polishing process: Following laser processing, magnetorheology‑assisted nano‑abrasion and micro‑current precision electropolishing are introduced. The former uses intelligent magnetic abrasive flow for flexible finishing of complex inner lumens; the latter selectively dissolves micro‑protrusions via precisely controlled electric current and electrolyte, forming a uniform, dense, chromium‑rich passive oxide layer on both inner and outer cannula surfaces to deliver dual protection of physical smoothness and chemical passivation.

Mechanism of Action

New materials and advanced processes jointly safeguard fistula health through synergistic physical, chemical and hydrodynamic mechanisms:

The extreme corrosion resistance of high‑purity 316L‑VAR material preserves surface integrity even after prolonged blood contact and repeated exposure to disinfectants such as sodium hypochlorite, fundamentally eliminating chemical irritation to vascular endothelium caused by leached metal ions and maintaining long‑term fistula patency.

Optimised side holes and drainage slots formed via 5‑axis laser cutting alter blood flow patterns within cannulas. Conventional end‑hole needles easily induce a suction effect during high‑speed blood withdrawal, leading to wall‑adhered orifices, poor blood flow and even tissue injury. Multi‑side‑hole and spiral drainage‑slot designs enable uniform, stable laminar flow, lowering blood‑flow shear stress and reducing mechanical damage to blood cells as well as platelet activation.

Nanoscale mirror‑smooth inner surfaces transform blood‑metal contact into nearly friction‑free sliding. In accordance with the Hagen‑Poiseuille law, smooth tube walls significantly reduce fluid resistance. This means blood flows more smoothly at the same pump speed, allowing moderate optimisation of theoretical inner‑diameter requirements for puncture needles and facilitating less‑traumatic punctures.

Efficacy Validation

This product series has passed enhanced tests in compliance with ISO 7864 (Hypodermic Needles) and ASTM F3014 (Puncture Force of Hypodermic Needles), with over 100 000 clinical follow‑up applications completed at dialysis centres worldwide.

Material biocompatibility testing: Cytotoxicity, sensitisation and intradermal reactivity tests conducted in full compliance with ISO 10993 standards returned non‑reactive results. Long‑term immersion experiments simulating dialysate showed ion leaching levels below detection limits.

Hydrodynamic performance testing: At a simulated haemodialysis flow rate of 300 mL/min, turbulence intensity inside new multi‑side‑hole needles decreased by 60 % compared with conventional end‑hole needles, effectively reducing haemolysis risks.

Clinical puncture study: Among patients with mature fistulae subjected to ≥ 100 punctures, the average Visual Analogue Scale (VAS) puncture pain score decreased by 1.8 points with the new needles. Under ultrasound monitoring, the incidence of peripunctural vascular wall oedema and intimal tearing fell by 35 %.

R&D Strategy and Philosophy

Manners Technology's R&D strategy in this field is applying aerospace‑grade materials and precision manufacturing to routine ground‑level medical care. Its core philosophy holds that for dialysis patients, AVF needles are not ordinary consumables but high‑frequency precision interface devices sustaining life. Therefore, quality benchmarks should go beyond "functional" to achieve ultimate safety, ultimate smoothness and ultimate durability. Partnering with national engineering laboratories for materials, it conducts long‑term research on in‑vivo and in‑vitro corrosion behaviours of metallic materials, adopting "zero ion leaching, zero surface defects" as non‑negotiable bottom‑line requirements. Its manufacturing philosophy centres on prevention rather than remediation, eliminating all potential downstream risks through upstream extreme control of materials and processes.

Future Outlook

Future material and manufacturing developments for AVF needles will evolve toward bio‑functionalisation and intelligent sensing. Manufacturers are developing biomimetic endothelial coatings: building on mirror polishing, phospholipid polymer coatings are grafted to mimic the lubricating and anticoagulant properties of vascular inner linings, theoretically completely preventing thrombus adhesion. Another direction explores bioabsorbable alloys for needle tip fabrication: micro‑tips retained after puncture degrade within days and release anti‑proliferative drugs to inhibit scar hyperplasia at puncture sites. More cutting‑edge research integrates miniature fibre‑optic sensors into needle walls to monitor real‑time parameters including tissue pressure, blood flow velocity and haematocrit during puncture, providing instant data for precision puncture and dialysis prescription adjustment. The manufacturer aims to evolve AVF needles from mere blood‑flow channels into intelligent life‑information interaction terminals.